Common Equity (Annual)

Common Equity: The sum of all common equity items.

NeuroOne Medical Technologies Corporation (NMTC) had Common Equity of $0.82M for the most recently reported fiscal year, ending 2024-09-30.

Quarterly Annual

Figures for fiscal year ending 2024-09-30

Income Statement Financials
Revenue	$3.45M
Net Income	$-12.32M
Cost of Goods Sold	$2.37M
Gross Profit	$1.08M
Operating Expenses	$15.34M
Operating Income	$-11.89M
Non-Operating Income/Expense	$-0.43M
Pre-Tax Income	$-12.32M
Normalized Pre-Tax Income	$-12.32M
Income after Taxes	$-12.32M
Income from Continuous Operations	$-12.32M
Consolidated Net Income/Loss	$-12.32M
Normalized Income after Taxes	$-12.32M
EBIT	$-11.89M
EBITDA	$-11.54M
Weighted-Average Shares Outstanding (Basic)	26.76M
Weighted-Average Shares Outstanding (Diluted)	26.76M
Earnings per Share (EPS) (Basic)	$-0.46
Earnings per Share (EPS) (Diluted)	$-0.46
Balance Sheet Financials
Current Assets	$4.63M
Property, Plant, and Equipment	$0.42M
Long-Term Assets	$0.74M
Total Assets	$5.37M
Current Liabilities	$2.21M
Long-Term Debt	--
Long-Term Liabilities	$2.33M
Total Liabilities	$4.55M
Common Equity	$0.82M
Tangible Shareholders Equity	$0.75M
Shareholders Equity	$0.82M
Common Shares Outstanding	30.82M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-11.01M
Cash Flow from Investing Activities	$-0.12M
Cash Flow from Financial Activities	$7.27M
Beginning Cash	$5.32M
End Cash	$1.46M
Increase/Decrease in Cash	$-3.86M
Stock-Based Compensation	$1.34M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.09
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	31.27%
Operating Margin	-344.26%
EBIT Margin	-344.26%
EBITDA Margin	-334.18%
Pre-Tax Profit Margin	-356.74%
Profit Margin	-356.74%
Free Cash Flow	$-11.13M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.64
Inventory Turnover	0.90
Receiveable Turnover	19.55
Days Sales in Receivables	18.67
Return on Equity	-1498.53%
Return on Tangible Equity	-1632.08%
Return on Assets	-229.39%
Return on Investments	-1498.53%
Book Value Per Share	$0.03
Free Cash Flow per Share	$-0.42
Operating Cash Flow per Share	$-0.41

Data from Zacks Investment Research, Inc.